Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Acceleron Pharma Inc. Stock Price (Quote) NASDAQ:XLRN
$173.78 ( -0.0977% ) Monday, 25th Oct 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $171.75 | $189.99 | Monday, 25th Oct 2021 XLRN stock ended at $173.78. This is 0.0977% less than the trading day before Friday, 22nd Oct 2021. During the day the stock fluctuated 0.61% from a day low at $173.51 to a day high of $174.57. |
| 90 days | $115.13 | $189.99 | |
| 52 weeks | $99.98 | $189.99 |
Historical Acceleron Pharma Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2021-10-25 | $174.41 | $174.57 | $173.51 | $173.78 | 335 689 |
| 2021-10-22 | $174.23 | $174.42 | $173.50 | $173.95 | 196 689 |
| 2021-10-21 | $174.00 | $174.35 | $173.10 | $173.75 | 633 860 |
| 2021-10-20 | $173.77 | $174.25 | $172.25 | $172.51 | 493 673 |
| 2021-10-19 | $173.04 | $174.30 | $173.04 | $173.74 | 363 155 |
| 2021-10-18 | $173.25 | $174.40 | $172.85 | $173.00 | 611 183 |
| 2021-10-15 | $172.93 | $173.55 | $171.91 | $172.94 | 408 525 |
| 2021-10-14 | $173.75 | $174.86 | $172.02 | $172.08 | 1 123 163 |
| 2021-10-13 | $173.75 | $174.30 | $172.23 | $172.59 | 1 074 534 |
| 2021-10-12 | $175.34 | $179.49 | $173.28 | $173.78 | 2 481 419 |
| 2021-10-11 | $175.10 | $175.89 | $174.49 | $174.99 | 861 410 |
| 2021-10-08 | $175.80 | $176.19 | $174.81 | $175.00 | 1 270 145 |
| 2021-10-07 | $175.87 | $176.50 | $175.03 | $175.33 | 2 100 158 |
| 2021-10-06 | $176.62 | $176.97 | $175.27 | $175.29 | 1 100 710 |
| 2021-10-05 | $174.99 | $177.20 | $174.24 | $177.13 | 2 104 444 |
| 2021-10-04 | $173.63 | $175.23 | $173.21 | $174.68 | 1 564 654 |
| 2021-10-01 | $172.50 | $175.07 | $172.27 | $174.35 | 2 789 745 |
| 2021-09-30 | $175.09 | $175.60 | $171.75 | $172.10 | 14 630 860 |
| 2021-09-29 | $183.00 | $189.99 | $175.25 | $175.36 | 4 036 773 |
| 2021-09-28 | $179.49 | $187.70 | $178.60 | $182.78 | 2 095 611 |
| 2021-09-27 | $173.00 | $182.44 | $173.00 | $178.87 | 1 869 314 |
| 2021-09-24 | $158.94 | $174.24 | $158.52 | $167.65 | 1 223 160 |
| 2021-09-23 | $154.69 | $161.35 | $154.57 | $159.84 | 767 897 |
| 2021-09-22 | $153.36 | $154.72 | $149.33 | $154.44 | 364 497 |
| 2021-09-21 | $140.46 | $153.86 | $139.76 | $153.29 | 1 013 292 |
| 2021-09-20 | $135.94 | $140.06 | $134.99 | $139.55 | 437 632 |
| 2021-09-17 | $133.77 | $137.96 | $131.20 | $137.60 | 425 065 |
| 2021-09-16 | $134.22 | $134.70 | $130.07 | $133.77 | 134 967 |
| 2021-09-15 | $131.87 | $136.50 | $131.62 | $134.16 | 305 832 |
| 2021-09-14 | $132.54 | $133.75 | $131.50 | $132.19 | 99 057 |
| 2021-09-13 | $133.23 | $134.59 | $132.39 | $132.58 | 114 581 |
| 2021-09-10 | $131.73 | $133.06 | $129.35 | $132.43 | 148 168 |
| 2021-09-09 | $130.00 | $131.90 | $128.91 | $130.97 | 128 520 |
| 2021-09-08 | $129.55 | $129.93 | $127.42 | $129.51 | 117 799 |
| 2021-09-07 | $130.81 | $131.56 | $128.89 | $129.36 | 87 840 |
| 2021-09-03 | $132.06 | $133.49 | $130.54 | $131.32 | 120 813 |
| 2021-09-02 | $130.70 | $131.89 | $128.87 | $131.82 | 309 139 |
| 2021-09-01 | $133.88 | $135.69 | $129.28 | $129.70 | 430 236 |
| 2021-08-31 | $133.20 | $135.49 | $133.20 | $133.88 | 322 632 |
| 2021-08-30 | $129.97 | $132.95 | $129.97 | $132.76 | 201 766 |
| 2021-08-27 | $126.82 | $130.45 | $126.49 | $129.52 | 148 588 |
| 2021-08-26 | $127.47 | $130.11 | $127.16 | $127.16 | 213 992 |
| 2021-08-25 | $125.24 | $127.91 | $123.87 | $127.08 | 156 173 |
| 2021-08-24 | $125.28 | $125.28 | $120.39 | $125.24 | 143 316 |
| 2021-08-23 | $123.67 | $125.72 | $122.60 | $125.13 | 347 142 |
| 2021-08-20 | $120.43 | $122.57 | $120.20 | $122.14 | 187 683 |
| 2021-08-19 | $123.76 | $125.41 | $119.31 | $119.99 | 224 815 |
| 2021-08-18 | $125.38 | $126.31 | $124.06 | $124.61 | 150 659 |
| 2021-08-17 | $121.13 | $125.06 | $121.13 | $124.81 | 257 939 |
| 2021-08-16 | $122.00 | $123.22 | $120.31 | $122.22 | 129 709 |
Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
